Thermo Fisher Scientific Inc. Stock Lima
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
585 USD | 0.00% | 0.00% | +13.20% |
Financials (USD)
Sales 2024 * | 43.02B | Sales 2025 * | 46.1B | Capitalization | 223B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B | Net income 2025 * | 6.97B | EV / Sales 2024 * | 5.73 x |
Net Debt 2024 * | 23.49B | Net Debt 2025 * | 19.14B | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
36
x | P/E ratio 2025 * |
30.8
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
3 months | +5.79% | ||
6 months | +32.12% | ||
Current year | +13.20% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-27 | 585 | 0.00% |
24-05-24 | 585 | 0.00% |
24-05-23 | 585 | 0.00% |
24-05-22 | 585 | 0.00% |
24-05-21 | 585 | 0.00% |
End-of-day quote Lima, May 26, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B | |
+20.43% | 31.33B |
- Stock Market
- Equities
- TMO Stock
- TMO Stock